Nasdaq Healthcare: Closing on January 17th

Friday's session presented a retracement on the 20 EMA Line, as predicted. I still believe in the continuation of the bullish trend. However, the bearish divergence needs to be monitored, since further price correction could occur.

Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties.
Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.
I am not a financial advisor
Beyond Technical AnalysisbiotechbiotechnologybiotechstockshealthcarehealthcarestockshealthequityTechnical IndicatorspharmaceuticalspharmastocksTrend Analysis

Również na:

Powiązane publikacje

Wyłączenie odpowiedzialności